• FirefoxInstall the new Firefox »
  •  Dow Up0.21% Nasdaq Up0.32%

    More On SPH.L

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Sinclair IS Pharma plc (SPH.L)

    -LSE
    36.42 Up 0.17(0.47%) 5:51AM EST
    Add to Portfolio
    ProfileGet Profile for:
    Sinclair IS Pharma plc
    Whitfield Court
    1st Floor
    London, W1T 2RQ
    United Kingdom - Map
    Phone: 44 20 7467 6920
    Fax: 44 20 7467 6930
    Website: http://www.sinclairispharma.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Major
    Full Time Employees:161

    Business Summary 

    Sinclair IS Pharma plc, a specialty pharmaceutical company, provides surface technology and delivery systems for aesthetics, wound care, and skin care treatments worldwide. The company’s aesthetic dermatology solutions include Kelo-cote, a topical silicone gel used for the management and prevention of hypertrophic and keloid scars; Kelo-Stretch, which helps in rebuilding damaged collagen and regaining skin elasticity; Sculptra, a volumizer designed to stimulate natural collagen growth; Perfectha for the treatment of wrinkles and facial contours; Ellansé, which offers four dermal filler options for facial aesthetic treatments; and Silhouette Soft, a skin tightening and own collagen stimulator. Its wound care products comprise Flammazine and Flammacerium that are used in the prevention and treatment of severe burns and wounds; and Aloclair Plus for relieving the pain caused by aphthous mouth ulcers and other minor oral lesions. The company’s skin care products include Atopiclair, a non-steroidal topical treatment for the symptomatic relief of atopic, contact allergic, and irritant dermatitis; Papulex, a dermocosmetic product used for cleansing, hydrating, and protecting acne prone skin; Sebclair for the management of skin and scalp seborrhoeic dermatitis; and Bio-Taches products for preventing and reducing pigmentation disorders, such as chloasma, melasma, or dyschromia. Further, it offers other products consisting of Variquel/Haemopressin for the treatment of bleeding oesophageal varices; Aloxi, a 2nd generation 5HT3 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting associated with highly emetogenic chemotherapy and moderately emetogenic chemotherapy; and Decapinol for plaque management. Sinclair IS Pharma plc offers its solutions to hospitals, plastic surgeons, dermatologists, and pharmacists. The company was founded in 1971 and is headquartered in London, the United Kingdom.

    Key Statistics


    Company Websites 
    Home Page
    Investor Relations
    Search Yahoo! for:
    More on Sinclair IS Pharma plc

    Key Executives 
     PayExercised
    Mr. Christopher P. Spooner ,
    Chief Exec. Officer and Director
    632.00KN/A
    Mr. Christophe H. Foucher ,
    Chief Operating Officer and Director
    408.00KN/A
    Mr. Alan Olby ACA, B.A. , 44
    Chief Financial Officer
    N/AN/A
    Mrs. Ann Hardy BSc (Hons), 56
    Global Technical Director
    N/AN/A
    Mr. Simon Youlton ,
    Commercial Chief Scientific Officer and Head of In-Licensing
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in GBp.